London: AstraZeneca CEO Pascal Soriot achieved a landmark victory on Friday as U.S. President Donald Trump announced a historic medicine deal designed to reduce prescription drug costs for millions of Americans. The agreement marks the first time a non-U.S. pharmaceutical company has negotiated directly with the U.S. administration to secure favorable terms while avoiding steep threatened tariffs on imported drugs.

The culmination of months of strategic engagement, the deal reflects Soriot’s persistent diplomacy and deft maneuvering post-2024 U.S. election. Sources close to the negotiations revealed that discussions began immediately after Trump’s victory, spanning both private and public meetings. Soriot’s charm offensive included attending a royal banquet in Windsor Castle and multipl

See Full Page